Anat Frydman‐Marom

Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder

Paul Gringras, Tali Nir, John Breddy et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2017 · 296 citations · Full text

Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models

Anat Frydman‐Marom, Aviad Levin, Dorit Farfara et al. · PLoS ONE · 2011 · 191 citations · Full text

Neurochemical Biomarkers, Corrects Cognitive Impairment, Disease Animal Models +20

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial

Moshe Laudon, Alan Wade, Mildred V. Farmer et al. · Clinical Interventions in Aging · 2014 · 168 citations · Full text

Inhibition of Amyloid Fibril Formation and Cytotoxicity by Hydroxyindole Derivatives

Tomer Cohen, Anat Frydman‐Marom, Meirav Rechter et al. · Biochemistry · 2006 · 154 citations

Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor

Roni Scherzer‐Attali, Riccardo Pellarin, Marino Convertino et al. · PLoS ONE · 2010 · 145 citations · Full text

Amyloid Oligomer Inhibitors, Neurochemical Biomarkers, Chemical Biology +22